Search

Thanks to a second opinion and minimally invasive surgery at MSK to remove tongue cancer, Karren Tyler is back home in Charlottesville, Virginia, cancer free and focused on giving back to other cancer patients.

… Monday, November 24, 2025 When Karren Tyler noticed a spot on the back of her tongue last year, she had it checked out by a doctor near her home in Charlottesville, Virginia, who told her it was probably nothing to worry about. But a week after having the spot removed and biopsied, Karren learned she

After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even after switching back to a normal diet.

… Friday, October 12, 2018 Bottom Line: After developing a noninvasive nanosensor to detect the progression of fatty liver disease in mice, researchers at the Sloan Kettering Institute have determined that there is a long-term effect on liver macrophages from eating a high-fat and high-sugar diet, even

Learn about dense breast tissue and what it means for your cancer risk and screening needs.

… Tuesday, May 27, 2025 Having dense breasts is a  risk factor for breast cancer . But how do you know if you have dense breasts, and how should it affect the way you approach screening for the disease? Radiologist Elise Desperito, MD , Director of Breast Imaging at the  MSK Ralph Lauren Center , shares

Learn how a heralded clinical trial for rectal cancer led to Dr. Andrea Cercek of MSK meeting the 4-day-old newborn of her patient, who feared she could not get pregnant.

… Tuesday, November 7, 2023 “Would you like to hold my baby?” Kelly Spill’s question to  Andrea Cercek, MD , is a familiar one from any proud par­ent. But as they sat together surrounded by Kelly’s family on her porch in southern New Jersey, that simple question took on a much more poignant meaning. As

A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled antibody accurately identifies whether a patient has clear cell renal carcinoma - the most common and aggressive type of renal tumor - and arms the urologist with crucial information that will help determine whether surgery is needed.

… Tuesday, March 6, 2007 The ability to identify an individual’s specific tumor type prior to surgery could have important implications for the management of patients diagnosed with kidney cancer . A newly published study demonstrates that imaging with Positron Emission Tomography (PET) using a radiolabeled

The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024.

… Thursday, January 23, 2025 The U.S. Food and Drug Administration (FDA) qualified MSK’s WOUND-Q™ questionnaire as a Medical Device Development Tool (MDDT) in November 2024. WOUND-Q is the latest of only 18 MDDTs that have earned the qualification since the MDDT program began in 2017. WOUND-Q contains

Cassidy Cobbs is many things: a valued colleague who works at the Sloan Kettering Institute; a doting parent to a pit bull named Mando; a beloved sibling; and a passionate baseball fan, who memorized the stats of former player, Ryne Sandberg, at the age of 5. What Cassidy is not is someone who identifies as either a man or a woman.

… Friday, March 31, 2023 Cassidy Cobbs is many things — A valued colleague and employee who works at the Sloan Kettering Institute  — the basic and translational research arm of Memorial Sloan Kettering Cancer Center (MSK). A doting parent to a pit bull named Mando. A beloved sibling. And a passionate

Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial.

… Monday, May 13, 2019 Reducing the radiation therapy dose currently used to treat high-risk neuroblastoma in children is possible, according to the promising results from our recent prospective trial, meaning reduced toxicities for many of these young patients. Our study, published in the International

Learn how a second opinion at a highly specialized cancer center such as MSK can lead to treatment that costs less and improves quality of life and survival.

… Tuesday, January 20, 2026 Many people who get a second opinion from highly specialized cancer experts may benefit from treatment that costs less, is less invasive, and improves quality of life and survival, according to new research conducted at Memorial Sloan Kettering Cancer Center (MSK). The study

For RuthAnn (“Ruthy”) Gordon, Director of Clinical Trials Nursing, some of the best days are when the FDA approves a drug from a clinical trial that she worked on. It’s happened to her four times.

… Monday, May 9, 2022 Clinical trials are research studies that test new drugs and therapies. MSK runs one of the largest clinical trials programs for cancer in the country — at any time, hundreds of clinical trials are underway at MSK locations in New York City and across the regional care network. Patients